Bio-Rad Laboratories, Inc. (BIO) short interest & options flow
NYSEBio-Rad Laboratories heads into the post-earnings stretch with a sharp divergence between what options markets are saying and what short sellers are actually doing. The clearest signal this week is in options. Demand for downside protection has jumped well above normal — the put/call ratio hit 0.55 on Tuesday, more than two and a half standard deviations above its 20-day mean of…
BIO cost to borrow jumps 126% in one week to 0.49%, reflecting tightening borrowing conditions after recent analyst upgrade.
- Market cap
- $10.45B
- Next earnings
- 11 Feb 2027
Key data as of 10 Nov 2026
Latest signals on BIO
- Cost to Borrow
BIO cost to borrow jumps 126% in one week to 0.49%, reflecting tightening borrowing conditions after recent analyst upgrade.
- Short Interest
BIO short interest falls 20.3% in one week to 4.42% of float, marking a sharp pullback from peak levels earlier this month.
BIO news and analysis
RSSNo long-form analysis yet for BIO. Pulse alerts and the live data picture are available on ORTEX.
Open BIO on ORTEX →Want the live picture for BIO?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BIO — free to start on ORTEX.
Sign up for free →Open BIO on ORTEX